Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101

Molecular Biotechnology

Volumn 29, Issue 3, 2005, Pages 191-196

  Yu, Fenggang ^a,b   Qi, Guoming ^b   Liu, Yanqing ^b   Gao, Shouyi ^b   Kan, Biao ^b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Homologous recombination; Mutant; ThyA; Vaccine; Vibrio cholerae

Indexed keywords

DISEASES; GENES; IMMUNOLOGY; MORPHOLOGY; VACCINES;

HOMOLOGOUS RECOMBINATION; MUTANT; THYA; VIBRIO CHOLERAE;

MUTAGENESIS;

CHOLERA VACCINE; THYMIDYLATE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; GENE VECTOR; HOMOLOGOUS RECOMBINATION; IMMUNOGENICITY; MOUSE; MUTANT; NONHUMAN; VIBRIO CHOLERAE;

ANIMALS; BACTERIAL PROTEINS; CHOLERA; CHOLERA TOXIN; CHOLERA VACCINES; HUMANS; IMMUNITY, MUCOSAL; RECOMBINATION, GENETIC; SEQUENCE DELETION; THYMIDYLATE SYNTHASE; VACCINES, ATTENUATED; VIBRIO CHOLERAE;

VIBRIO CHOLERAE;

EID: 26244441922     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:29:3:191     Document Type: Article

References (22)

1. Tauxe, R., Seminario, L., Taipia, R., and Libel, M. O. (1994) The Latin American epidemic. In: Vibrio cholerae and Cholera: Molecular to Global Perspectives (Wachsmuth, I. K., Blake, P. A., and Olsvik, Ø. eds.). ASM Press, Washington, DC, pp. 321-344.
2. Zhang, D., Xu, Z., Sun, W., and Karaolis, D. K. (2003) The vibrio pathogenicity island-encoded mop protein modulates the pathogenesis and reactogenicity of epidemic Vibrio cholerae. Infect. Immunol. 71, 510-515.
3. Mekalanos, J., Goldberg, I., Miller, V., et al. (1985) Genetic construction of cholera vaccine prototypes. In: Lerner, R., Chanock, R., and Brown, F., eds. Vaccines 85, Cold Spring Harbor, pp. 101-105.
4. Okada, T., Yanagisawa, K., and Ryan, F. J. (1960) Elective production of thymine-less mutants. Nature 188, 340-341.
5. Farmer, J. L. and Rothman, F. (1965) Transformable thymine-requiring mutant of Bacillus subtilis. J. Bacteriol. 89, 262-263.
6. Ross, P., O'Gara, F., and Condon, S. (1990) Cloning and characterization of the thymidylate synthase gene from Lactococcus lactis subsp. lactis. Appl. Environ. Microbiol. 56, 2156-2163.
7. Ross, P., O'Gara, F., and Condon, S. (1990) Thymidylate synthetase gene from Lactococcus lactis as a genetic marker: an alternative to antibiotic resistance genes. Appl. Environ. Microbiol. 56, 2164-2169.
8. Levine, M. M., Kaper, J. B., Herrington, D., et al. (1988) Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect. Immun. 56, 161-167.
9. Valle, E., Ledon, T., Cedre, B., et al. (2000) Construction and characterization of a nonproliferative El Tor cholera vaccine candidate derived from strain 638. Infect. Immun. 68, 6411-6418.
10. Liu, Y. Q., Qi, G. M., Wang, S. X., et al. (1995) A natural vaccine candidate strain against cholera. Biomed. Environ. Sci. 8, 350-358.
11. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. Michalski, J., Galen, J. E., Fasano, A., and Kaper, J. B. (1993) CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain. Infect. Immunol. 61, 4462-4468.
13. Hone, D. M., Harris, A. M., Chatfield, S., Dougan, G., and Levine, M. M. (1991) Construction of genetically defined double aro mutants of Salmonella typhi. Vaccine 9, 810-816.
14. Tison, D., Murray, P. R., and Baron, E. J. (eds.) (1999) Manual of Clinical Microbiology. Washington, DC, ASM Press, pp. 497-506.
15. Cedré, B., L. García, L., García, H., Fariñas, M., Talavera, A., and Infante, J. F. (1998) Intestinal colonization of the infant mouse model by attenuated and virulent Vibrio cholerae strains. Arch. Med. Res. 29, 231-234.
16. Attridge, S. R. (1995) Thymine auxotrophy as an attenuating marker in Vibrio cholerae. Microb. Pathog. 19, 11-18.
17. Liang, W., Wang, S., Yu, F., et al. (2003) Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Infect. Immun. 71, 5498-5504.
18. Miller, V. L. and Mekalanos J. J. (1988) A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requries toxR. J. Bacteriol. 170, 2575-2583.
19. Owen, R. L., Pierce, N. F., Apple, R. T., and Cray, W. C. Jr. (1996) M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J. Infect. Dis. 153, 1108-1118.
20. Winner, L. 3rd, Mack, J., Weltzin, R., Mekalanos, J. J., Kraehenbuhl, J. P., and Neutra, M. R. (1991) New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 59, 977-982.
21. Chen, I., Finn, T. M., Yanqing, L., Guoming, Q., Rappuoli, R., and Pizza, M. (1998) A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infect. Immun. 66, 1648-1653.
22. Fontana, M. R., Monaci, E., Yanqing, L., et al. (2001) IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin. Vaccine 19, 75-85.